ArticleArthritis research & therapy2024

Timely escalation to second-line therapies after failure of methotrexate in patients with early rheumatoid arthritis does not reduce the risk of becoming difficult-to-treat.

Bernardo D'Onofrio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.